MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with A

Alendronic acid

Alendronic acid 70mg effervescent tablets sugar free

No stability information

Stability notes for Alendronic acid 70mg effervescent tablets sugar free

There are no stability notes for this medicine.

Suppliers

Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd)
Binosto 70mg effervescent tablets (Necessity Supplies Ltd)

Alendronic acid 70mg tablets

No stability information

Stability notes for Alendronic acid 70mg tablets

There are no stability notes for this medicine.

Suppliers (17) of Alendronic acid 70mg tablets
Alendronic acid 70mg tablets (A A H Pharmaceuticals Ltd)
Alendronic acid 70mg tablets (Accord-UK Ltd)
Alendronic acid 70mg tablets (Alliance Healthcare (Distribution) Ltd)
Alendronic acid 70mg tablets (Almus Pharmaceuticals Ltd)
Alendronic acid 70mg tablets (Medihealth (Northern) Ltd)
Alendronic acid 70mg tablets (Medley Pharma Ltd)
Alendronic acid 70mg tablets (Milpharm Ltd)
Alendronic acid 70mg tablets (Phoenix Healthcare Distribution Ltd)
Alendronic acid 70mg tablets (Relonchem Ltd)
Alendronic acid 70mg tablets (Sandoz Ltd)
Alendronic acid 70mg tablets (Sigma Pharmaceuticals Plc)
Alendronic acid 70mg tablets (Somex Pharma)
Alendronic acid 70mg tablets (Teva UK Ltd)
Fosamax Once Weekly 70mg tablets (CST Pharma Ltd)
Fosamax Once Weekly 70mg tablets (Lexon (UK) Ltd)
Fosamax Once Weekly 70mg tablets (Organon Pharma (UK) Ltd)
Fosamax Once Weekly 70mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.